Exposure Clinical Trials

139 recruitingLast updated: June 18, 2026

There are 139 actively recruiting exposure clinical trials across 56 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1. Top locations include New York, New York, United States, San Francisco, California, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Exposure Trials at a Glance

139 actively recruiting trials for exposure are listed on ClinicalTrialsFinder across 6 cities in 56 countries. The largest study group is Not Applicable with 74 trials, with the heaviest enrollment activity in New York, San Francisco, and Chicago. Lead sponsors running exposure studies include University of California, San Francisco, University of North Carolina, Chapel Hill, and Columbia University.

Browse exposure trials by phase

Treatments under study

About Exposure Clinical Trials

Looking for clinical trials for Exposure? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Exposure trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Exposure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 139 trials

Recruiting
Phase 1Phase 2

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled19 locationsNCT07226986
Recruiting
Not Applicable

Behavioral Exposure for Introceptive Tolerance RCT

AnxietyCardiac RehabilitationExercise Sensitivity+1 more
Rutgers, The State University of New Jersey146 enrolled3 locationsNCT05398276
Recruiting

Human Observatory Study

Musculoskeletal DiseaseDisability PhysicalNeoplasms+16 more
Longevity Metrics, Inc.1,000,000 enrolled1 locationNCT07646782
Recruiting

Lung and Heart Function Across Decades of Life in Health

DyspneaPollution; ExposurePollution Related Respiratory Disorder+1 more
University of California, San Francisco200 enrolled1 locationNCT07641413
Recruiting

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Pollution; ExposureMicroplasticsNanoplastics+4 more
Azienda Ospedaliera "Sant'Andrea"120 enrolled6 locationsNCT07291609
Recruiting

Developmental Impacts of Microplastics Exposure in Early Life

Environmental ExposureInfant DevelopmentBreast Feeding
Johns Hopkins Bloomberg School of Public Health40 enrolled1 locationNCT06107933
Recruiting

Hospital Environmental Exposure

Air qualitySleepNoise exposure+2 more
University of Leicester120 enrolled1 locationNCT06802367
Recruiting
Phase 3

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,390 enrolled81 locationsNCT07044297
Recruiting

Climate Anxiety in a Young Population at Risk of Suicide

Mental Health IssueAnxietyEnvironmental Exposure+1 more
Centre Hospitalier Esquirol108 enrolled1 locationNCT07305688
Recruiting
Early Phase 1

Suture Lid Spring for Lid Closure in Patients With Facial Nerve Palsy

Paralytic LagophthalmosCorneal ExposureFacial Nerve Palsy
University of Alberta10 enrolled2 locationsNCT06895902
Recruiting
Not Applicable

HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

PrEPHIV Pre-Exposure Prophylaxis
University of Texas Southwestern Medical Center250 enrolled1 locationNCT07462611
Recruiting
Phase 3

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC4,580 enrolled30 locationsNCT07071623
Recruiting

NYU/Bellevue WTC Health Impacts Research Registry

Exposure to World Trade Center Dust
NYU Langone Health40,000 enrolled1 locationNCT00404898
Recruiting
Phase 1

Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)

Solid TumorsImmunotherapyCold Exposure+1 more
West China Hospital24 enrolled1 locationNCT07538479
Recruiting
Not Applicable

Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure

Cold Exposure
Indiana University30 enrolled1 locationNCT05822141
Recruiting
Not Applicable

Feasibility of Light Therapy in the Pediatric Intensive Care Unit (ICU)

Circadian DysregulationLight ExposurePediatric Critical Illness
Laura Beth Kalvas30 enrolled1 locationNCT07384585
Recruiting
Not Applicable

Self-Adhering Magnetic Device to Treat Corneal Exposure

Paralytic LagophthalmosCorneal Exposure
University of Illinois at Chicago25 enrolled1 locationNCT06291818
Recruiting
Not Applicable

Gathering Online for Dialogue and Discussion to Enhance Social Support

HIVPre-exposure ProphylaxisAlcohol Misuse+1 more
RTI International500 enrolled1 locationNCT05753683
Recruiting
Not Applicable

HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
University of Washington30,000 enrolled1 locationNCT07089966
Recruiting
Not Applicable

Randomized Trial of Next Generation Fluoroscopy System vs. Conventional Fluoroscopy System in Endoscopy

Radiation Exposure
Orlando Health, Inc.108 enrolled1 locationNCT07594132